Related Experiment Video
Updated: May 16, 2026

A Protocol to Characterize the Morphological Changes of Clostridium difficile in Response to Antibiotic Treatment
Published on: May 25, 2017
Recent trends in the epidemiology and treatment of C. difficile infection in children
Julia Shaklee Sammons1, Philip Toltzis
1Division of Infectious Diseases and Department of Infection Prevention and Control, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
Insights
Clostridium difficile infection (CDI) is rising in children, necessitating increased awareness among pediatric providers. While antibiotics remain primary treatment, new therapies are emerging for this common healthcare-associated diarrhea.
Area of Science:
- Pediatric Infectious Diseases
- Microbiology
- Epidemiology
Background:
- Clostridium difficile is a leading cause of healthcare-associated diarrhea in adults and an emerging pathogen in children.
- Recent trends show a significant increase in Clostridium difficile infection (CDI) incidence across pediatric settings.
Purpose of the Study:
- To provide pediatric providers with an updated overview of the epidemiology of Clostridium difficile infection (CDI) in children.
- To summarize current and emerging therapeutic options for pediatric CDI.
Main Methods:
- This is a review article, synthesizing existing literature on CDI epidemiology and treatment in pediatric populations.
- Analysis of trends in CDI incidence among children in inpatient and outpatient settings.
Main Results:
- CDI incidence has more than doubled in adults and is increasing in children, with specific pediatric groups at higher risk.
- Antibiotic therapies are standard for CDI, but novel treatments are under development.
- Non-antibiotic therapies are less common in children but studied in adults for severe or recurrent cases.
Conclusions:
- The increasing incidence of CDI in children requires greater recognition by pediatric healthcare providers.
- Understanding high-risk pediatric populations and available therapies is crucial for managing this evolving disease.
Purpose Of Review:
Clostridium difficile is the most common cause of healthcare-associated diarrhea among adults in Western countries, and is increasingly recognized as an important pathogen in children. This review provides an update on the changing epidemiology of C. difficile infection (CDI) for pediatric providers and summarizes current knowledge regarding available therapies.
Recent Findings:
The incidence of CDI has more than doubled among adults over the past decade, with a particular rise in incidence among patients presenting from the community. CDI has also increased among children in both inpatient and outpatient settings and there is growing evidence that specific populations of children may be at highest risk. Antibiotic-based therapies remain the mainstay of treatment for CDI, but new therapies have been developed with potential future applications in children. Use of nonantibiotic-based therapies is limited in children, but their use has been studied among adults with intractable or recurrent disease.
Summary:
The rise in incidence of CDI over the past decade warrants increased recognition by pediatric providers. Knowledge of the pediatric populations at highest risk for infection as well as the options for therapy will improve understanding of this changing disease.
Related Concept Videos
Pharmacokinetics in Pediatric Patients: Drug Excretion
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption
Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Clinical Significance of Antibiotic Resistance
Bacterial Gastroenteritis
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
